WallStreetZenWallStreetZen

NASDAQ: RLMD
Relmada Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Relmada Therapeutics earnings were -$56.2M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest RLMD earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$10.1M, up 2.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RLMD reported annual earnings of -$80.0M, with -19% growth. The next RLMD earnings date is Mar 24, 2026.

RLMD earnings history

Current Revenue
$0.0
Current Earnings
-$56.2M
Current Profit Margin
0%

RLMD Return on Equity

Current Company
-269.5%
Current Industry
-21.2%
Current Market
35.1%
RLMD's Return on Equity (-269.5%)... subscribe to Premium to read more.
High Return on Equity Performance

RLMD Return on Assets

Current Company
-205.2%
Current Industry
-8.8%
RLMD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RLMD announces earnings.

RLMD Return on Capital Employed

Current Company
-579.92%
Current Industry
-3.5%
RLMD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RLMD vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RLMD-$56.17M-$56.17MN/A-$1.80
ARMP-$30.37M-$46.90MN/A-$1.29
XOMA$26.75M$16.60M+43.69%$0.81
XFOR-$81.78M-$95.10MN/A-$10.12
LRMR-$131.92M-$132.00MN/A-$1.94
View Top Biotech Stocks

RLMD earnings dates

Next earnings date
Mar 24, 2026

Relmada Therapeutics Earnings Reports & History FAQ

What were Relmada Therapeutics's earnings last quarter?

On RLMD's earnings call on Invalid Date, Relmada Therapeutics (NASDAQ: RLMD) reported Q3 2025 earnings per share (EPS) of -$0.30, up 58.33% year over year. Total RLMD earnings for the quarter were -$10.09 million. In the same quarter last year, Relmada Therapeutics's earnings per share (EPS) was -$0.72.

If you're new to stock investing, here's how to buy Relmada Therapeutics stock.

When does Relmada Therapeutics report earnings?

The next RLMD earnings call is Invalid Date. Add RLMD to your watchlist to be reminded of Relmada Therapeutics's next earnings date.

Is Relmada Therapeutics profitable or losing money?

As of the last Relmada Therapeutics earnings report, Relmada Therapeutics is currently losing money. Relmada Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$56.17 million, a 35.05% decrease year over year.

What was RLMD's earnings growth in the past year?

As of Relmada Therapeutics's earnings date in Invalid Date, Relmada Therapeutics's earnings has grown year over year. RLMD earnings in the past year totalled -$56.17 million.

What are Relmada Therapeutics's earnings expectations?

The current EPS estimate for Relmada Therapeutics's earnings report in Invalid Date is -$0.17.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.